October 5, 2020 Artoss, Inc. Announces Record Sales of NanoBone Bone Graft »

​

April 24, 2019 Artoss, Inc. Announces FDA Clearance of NanoBone SBX Putty for Standalone Use in Posterolateral Spinal Fusion »

​

March 28, 2019  Artoss, Inc. Announces Hiring of Gabriel "Gabe" Ortiz as Director of Sales, Western Region

​

September 24, 2018  Artoss, Inc. Announces Hiring of William “Billy” Lapp as Director of Sales, East Coast. Further expansion of U.S. presence supporting commercialization

​

September 24, 2018  Artoss Announces Completion of $1 Million Funding Round. Financing allows expanded U.S. commercial and clinical presence

​

October 23, 2017  Artoss Announces NanoBone® QD Bone Graft. NanoBone QD allows for expanded orthopaedic clinical use

​

October 9, 2017  Artoss, Inc. Announces Hiring of Ryan O’Neill as Director of Sales, Eastern Region. Experienced Sales Background Supports NanoBone Efforts

​

September 15, 2017  Artoss, Inc. Announces DAPA Agreement for NanoBone® Bone Graft Products.  Expands NanoBone U.S. Commercial Opportunities

​

November 8, 2016  Artoss Announces FDA Clearance to Market of NanoBone SBX Putty. Clearance Expands NanoBone role in U.S. Orthopaedic Surgery